Acquirer | Target | Price |
---|---|---|
Juno Therapeutics, Inc. | AbVitro, Inc. | $122.8 million |
Satellite Healthcare, Inc. | 3 dialysis centers | N/A |
MiMedix Group Inc. | Stability Biologics | $10 million |
Shire plc | Baxalta Inc. | $32 billion |
Roche | Tensha Therapeutics | $115 million |
U.S. HealthWorks | Muir/Diablo Occupational Medicine | N/A |